US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PagerDuty, Inc.

15.34

-0.2400-1.54%

Post-market: 15.340.00000.00%19:35 EDT

Volume:1.19M

Turnover:18.38M

Market Cap:1.21B

PE:7.56

High:15.86

Open:15.58

Low:15.24

Close:15.58

52wk High:16.77

52wk Low:5.70

Shares:78.65M

Float Shares:70.64M

Volume Ratio:0.59

T/O Rate:1.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.03

EPS(LYR):1.87

ROE:82.56%

ROA:2.29%

PB:5.20

PE(LYR):8.20

Loading ...

Overview Company News Filings

PagerDuty Appoints Eric Prengel as Chief Financial Officer

THOMSON REUTERS

How Investors Are Reacting To Agilent Technologies (A) Expanding PD-L1 Test Use And Launching New AI Partnership

Simply Wall St.

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

SIMCERE PHARMA Receives NMPA Approval for Clinical Trial of SIM0689, a Dual-Target Antibody

Simcere Wins NMPA Green Light for PD-1/VEGF Bispecific Cancer Therapy

PagerDuty survey finds 66% of office professionals use unauthorized AI tools at work

Press Release: AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease

Southwest Securities: Post-PD-(L)1 Treatment Resistance Poses Significant Challenge, 2026 to See High Concentration of Catalysts

PagerDuty announces Ingram Micro as authorized distributor in Australia

PagerDuty names Ingram Micro exclusive distributor in Australia

PagerDuty Expands Australia Footprint With Exclusive Distribution Agreement With Ingram Micro

THOMSON REUTERS

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease

PagerDuty price target raised to $10 from $7 at Morgan Stanley

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

Agilent receives FDA approval for expanded use of PD-L1 IHC 22C3 pharmDx

PagerDuty management presents at BofA Securities Global Technology Conference

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/PD/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","market":"US","secType":"STK","nameCN":"PagerDuty, Inc.","latestPrice":15.34,"timestamp":1790971200000,"preClose":15.58,"halted":0,"volume":1194603,"hourTrading":{"tag":"盘后","latestPrice":15.34,"preClose":15.34,"latestTime":"19:35 EDT","volume":43520,"amount":667551.2102,"timestamp":1790984120186,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.015404364569961502,"floatShares":70635553,"shares":78649873,"eps":2.03,"marketStatus":"Market Closed","change":-0.24,"latestTime":"10-02 16:00:00 EDT","open":15.58,"high":15.86,"low":15.24,"amount":18382543.796382003,"amplitude":0.039795,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.03,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1554955200000,"exchange":"NYSE","adjPreClose":15.58,"preHourTrading":{"tag":"盘前","latestPrice":15.61,"preClose":15.58,"latestTime":"09:29 EDT","volume":355,"amount":5575.3509699999995,"timestamp":1790947791084,"change":0.03,"changeRate":0.001926,"amplitude":0.012195},"postHourTrading":{"tag":"盘后","latestPrice":15.34,"preClose":15.34,"latestTime":"19:35 EDT","volume":43520,"amount":667551.2102,"timestamp":1790984120186,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5923869981975955,"impliedVol":0.6444,"impliedVolPercentile":0.2829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PD\",,,,,undefined,":{"symbol":"PD","floatShares":70635553,"roa":"2.29%","roe":"82.56%","lyrEps":1.87,"volumeRatio":0.5923869981975955,"shares":78649873,"dividePrice":0,"high":15.86,"amplitude":0.039795,"preClose":15.58,"low":15.24,"week52Low":5.7,"pbRate":"5.20","psRate":"2.44","week52High":16.77,"institutionHeld":0,"latestPrice":15.34,"eps":2.03,"divideRate":0,"volume":1194603,"delay":0,"ttmEps":2.03,"open":15.58,"prevYearClose":13.11,"prevWeekClose":14.38,"prevMonthClose":15.1,"prevQuarterClose":15.1,"fiveDayClose":14.38,"twentyDayClose":14.1,"sixtyDayClose":10.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PD\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"PD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/07","expectedEps":0.12,"defaultRemindTime":1787860800000,"name":null,"time":"Post-Mkt","dateTimestamp":1787803200000,"actualEps":null},{"market":"US","date":"2026-05-28","symbol":"PD","fiscalQuarterEnding":"2026/04","expectedEps":0.03,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1779940800000,"reportTimeType":"post","actualEps":0.1},{"market":"US","date":"2026-03-12","symbol":"PD","fiscalQuarterEnding":"2026/01","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-11-25","symbol":"PD","fiscalQuarterEnding":"2025/10","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1764046800000,"reportTimeType":"post","actualEps":0.15},{"date":"2025-09-03","symbol":"PD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/07","expectedEps":-0.02,"defaultRemindTime":1756929600000,"name":null,"time":"Post-Mkt","dateTimestamp":1756872000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.4444,"sell":0.2222,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4444,"analysts":9,"updateTime":1784692800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PD","date":"2026-10-02","current":7.55665,"percent":0.965975,"low":-115.332138,"twenty":-28.831325,"median":-21.327334,"eighty":-16.042428,"high":9.29824,"avg":-23.185687,"sd":22.662303,"marketCap":1212914856},"quantilePoints":[{"date":"2021-10-08","current":-35.304169,"twenty":-63.234694,"median":-44.895964,"eighty":-39.361418,"marketCap":3353013468},{"date":"2021-10-15","current":-36.968279,"twenty":-62.977151,"median":-44.757709,"eighty":-39.195032,"marketCap":3511062253},{"date":"2021-10-22","current":-37.567716,"twenty":-62.673,"median":-44.689179,"eighty":-39.048237,"marketCap":3567993805},{"date":"2021-10-29","current":-37.352992,"twenty":-62.144822,"median":-44.662724,"eighty":-38.884343,"marketCap":3547600413},{"date":"2021-11-05","current":-38.927633,"twenty":-61.970673,"median":-44.622066,"eighty":-38.780249,"marketCap":3697151952},{"date":"2021-11-12","current":-37.684024,"twenty":-61.914834,"median":-44.517265,"eighty":-38.690435,"marketCap":3579040225},{"date":"2021-11-19","current":-34.892615,"twenty":-61.891288,"median":-44.350719,"eighty":-38.663132,"marketCap":3313926135},{"date":"2021-11-26","current":-33.094304,"twenty":-61.87812,"median":-44.340807,"eighty":-38.647574,"marketCap":3143131480},{"date":"2021-12-03","current":-27.717262,"twenty":-61.851785,"median":-44.310434,"eighty":-38.490518,"marketCap":2632446965},{"date":"2021-12-10","current":-29.437491,"twenty":-61.634212,"median":-44.193031,"eighty":-38.342002,"marketCap":2964590848},{"date":"2021-12-17","current":-29.446029,"twenty":-61.446371,"median":-44.130431,"eighty":-38.122419,"marketCap":2965450648},{"date":"2021-12-23","current":-30.863263,"twenty":-61.141525,"median":-44.120926,"eighty":-37.910083,"marketCap":3108177469},{"date":"2021-12-31","current":-29.668005,"twenty":-60.679678,"median":-44.096614,"eighty":-37.767931,"marketCap":2987805451},{"date":"2022-01-07","current":-27.243339,"twenty":-60.561077,"median":-44.020576,"eighty":-37.685906,"marketCap":2743622214},{"date":"2022-01-14","current":-26.466422,"twenty":-60.402519,"median":-43.931787,"eighty":-37.609143,"marketCap":2665380403},{"date":"2022-01-21","current":-25.715117,"twenty":-60.229637,"median":-43.82863,"eighty":-37.535067,"marketCap":2589717991},{"date":"2022-01-28","current":-27.448241,"twenty":-60.179262,"median":-43.748751,"eighty":-37.457573,"marketCap":2764257417},{"date":"2022-02-04","current":-27.106738,"twenty":-60.125395,"median":-43.643849,"eighty":-37.310047,"marketCap":2729865412},{"date":"2022-02-11","current":-28.728874,"twenty":-59.884929,"median":-43.550718,"eighty":-37.143446,"marketCap":2893227437},{"date":"2022-02-18","current":-27.106738,"twenty":-59.724487,"median":-43.492185,"eighty":-36.968378,"marketCap":2729865412},{"date":"2022-02-25","current":-28.071482,"twenty":-59.678646,"median":-43.437917,"eighty":-36.905651,"marketCap":2827022827},{"date":"2022-03-04","current":-25.322389,"twenty":-59.583656,"median":-43.360924,"eighty":-36.834452,"marketCap":2550167185},{"date":"2022-03-11","current":-22.70136,"twenty":-59.306192,"median":-43.319423,"eighty":-36.766338,"marketCap":2286208545},{"date":"2022-03-18","current":-28.291592,"twenty":-59.172166,"median":-43.295217,"eighty":-36.444632,"marketCap":3040073042},{"date":"2022-03-25","current":-28.785804,"twenty":-59.048339,"median":-43.241759,"eighty":-36.064649,"marketCap":3093178556},{"date":"2022-04-01","current":-27.724464,"twenty":-59.048339,"median":-43.1764,"eighty":-35.678665,"marketCap":2979132288},{"date":"2022-04-08","current":-25.415442,"twenty":-58.958192,"median":-43.086807,"eighty":-35.293402,"marketCap":2731016361},{"date":"2022-04-14","current":-26.428171,"twenty":-58.866018,"median":-43.039133,"eighty":-34.945236,"marketCap":2839839136},{"date":"2022-04-22","current":-23.843687,"twenty":-58.778063,"median":-42.940117,"eighty":-34.48789,"marketCap":2562123414},{"date":"2022-04-29","current":-23.14693,"twenty":-58.704534,"median":-42.888728,"eighty":-33.407653,"marketCap":2487253345},{"date":"2022-05-06","current":-21.039181,"twenty":-58.614907,"median":-42.82356,"eighty":-33.196501,"marketCap":2260765197},{"date":"2022-05-13","current":-21.537198,"twenty":-58.533862,"median":-42.744231,"eighty":-33.138326,"marketCap":2314279623},{"date":"2022-05-20","current":-19.528801,"twenty":-58.506847,"median":-42.67719,"eighty":-32.784627,"marketCap":2098467346},{"date":"2022-05-27","current":-21.055509,"twenty":-58.47232,"median":-42.506172,"eighty":-32.56425,"marketCap":2262519768},{"date":"2022-06-03","current":-19.41561,"twenty":-58.365647,"median":-42.492303,"eighty":-32.253988,"marketCap":2285547362},{"date":"2022-06-10","current":-18.661968,"twenty":-58.119439,"median":-42.449993,"eighty":-31.627913,"marketCap":2196830881},{"date":"2022-06-17","current":-17.871017,"twenty":-57.794408,"median":-42.412967,"eighty":-30.853018,"marketCap":2103722495},{"date":"2022-06-24","current":-21.251213,"twenty":-57.545961,"median":-42.37641,"eighty":-30.527663,"marketCap":2501629088},{"date":"2022-07-01","current":-18.975364,"twenty":-57.27835,"median":-42.328632,"eighty":-30.205871,"marketCap":2233722883},{"date":"2022-07-08","current":-20.758734,"twenty":-57.119373,"median":-42.300639,"eighty":-29.937792,"marketCap":2443655942},{"date":"2022-07-15","current":-19.512613,"twenty":-57.022546,"median":-42.274674,"eighty":-29.686169,"marketCap":2296966315},{"date":"2022-07-22","current":-19.751391,"twenty":-56.538634,"median":-42.258991,"eighty":-29.576542,"marketCap":2325074507},{"date":"2022-07-29","current":-19.348454,"twenty":-55.37095,"median":-42.1379,"eighty":-29.489533,"marketCap":2277641933},{"date":"2022-08-05","current":-21.340755,"twenty":-54.581356,"median":-41.999461,"eighty":-29.249821,"marketCap":2512169660},{"date":"2022-08-12","current":-21.370602,"twenty":-54.282209,"median":-41.907002,"eighty":-28.899625,"marketCap":2515683184},{"date":"2022-08-19","current":-19.214141,"twenty":-54.164004,"median":-41.742363,"eighty":-28.761236,"marketCap":2261831075},{"date":"2022-08-26","current":-19.318607,"twenty":-54.013801,"median":-41.687142,"eighty":-28.490216,"marketCap":2274128409},{"date":"2022-09-02","current":-16.562766,"twenty":-53.825684,"median":-41.612639,"eighty":-28.401837,"marketCap":2096100841},{"date":"2022-09-09","current":-17.753369,"twenty":-53.67791,"median":-41.5952,"eighty":-28.368118,"marketCap":2246777593},{"date":"2022-09-16","current":-16.597991,"twenty":-53.584381,"median":-41.569297,"eighty":-28.257217,"marketCap":2100558733},{"date":"2022-09-23","current":-15.858267,"twenty":-53.533149,"median":-41.530643,"eighty":-28.105632,"marketCap":2006943000},{"date":"2022-09-30","current":-16.252786,"twenty":-53.345477,"median":-41.466004,"eighty":-27.873415,"marketCap":2056871391},{"date":"2022-10-07","current":-16.182337,"twenty":-53.110426,"median":-41.390601,"eighty":-27.717262,"marketCap":2047955607},{"date":"2022-10-14","current":-14.646529,"twenty":-52.79331,"median":-41.34773,"eighty":-27.636067,"marketCap":1853591514},{"date":"2022-10-21","current":-16.485271,"twenty":-52.578578,"median":-41.307589,"eighty":-27.328715,"marketCap":2086293479},{"date":"2022-10-28","current":-17.922449,"twenty":-52.484531,"median":-41.281723,"eighty":-27.012825,"marketCap":2268175475},{"date":"2022-11-04","current":-14.604259,"twenty":-52.445692,"median":-41.223096,"eighty":-26.683037,"marketCap":1848242043},{"date":"2022-11-11","current":-17.35885,"twenty":-52.440537,"median":-41.165581,"eighty":-26.46868,"marketCap":2196849202},{"date":"2022-11-18","current":-15.442613,"twenty":-51.97825,"median":-41.046215,"eighty":-26.415612,"marketCap":1954339874},{"date":"2022-11-25","current":-15.379208,"twenty":-51.971496,"median":-40.952393,"eighty":-26.24103,"marketCap":1946315669},{"date":"2022-12-02","current":-16.042428,"twenty":-51.941247,"median":-40.886211,"eighty":-26.002015,"marketCap":2129728606},{"date":"2022-12-09","current":-16.110204,"twenty":-51.872986,"median":-40.837833,"eighty":-25.713912,"marketCap":2138726192},{"date":"2022-12-16","current":-18.028246,"twenty":-51.7604,"median":-40.772608,"eighty":-25.598799,"marketCap":2393357876},{"date":"2022-12-23","current":-17.994359,"twenty":-51.70784,"median":-40.745253,"eighty":-25.338499,"marketCap":2388859083},{"date":"2022-12-30","current":-18.001136,"twenty":-51.570726,"median":-40.701201,"eighty":-25.184081,"marketCap":2389758841},{"date":"2023-01-06","current":-16.049206,"twenty":-51.363479,"median":-40.623172,"eighty":-24.85486,"marketCap":2130628364},{"date":"2023-01-13","current":-18.78733,"twenty":-51.102161,"median":-40.574619,"eighty":-24.231092,"marketCap":2494130839},{"date":"2023-01-20","current":-18.882216,"twenty":-50.978262,"median":-40.523325,"eighty":-23.99114,"marketCap":2506727459},{"date":"2023-01-27","current":-19.925957,"twenty":-50.965686,"median":-40.469321,"eighty":-23.312385,"marketCap":2645290284},{"date":"2023-02-03","current":-21.220466,"twenty":-50.951221,"median":-40.311267,"eighty":-22.57339,"marketCap":2817144176},{"date":"2023-02-10","current":-19.627745,"twenty":-50.890949,"median":-40.250171,"eighty":-21.596594,"marketCap":2605700905},{"date":"2023-02-17","current":-20.664708,"twenty":-50.876484,"median":-40.190227,"eighty":-21.430411,"marketCap":2743363971},{"date":"2023-02-24","current":-19.485417,"twenty":-50.857197,"median":-40.120759,"eighty":-21.251213,"marketCap":2586805975},{"date":"2023-03-03","current":-20.834146,"twenty":-50.688437,"median":-40.045986,"eighty":-21.055509,"marketCap":2765857936},{"date":"2023-03-10","current":-18.204462,"twenty":-50.646894,"median":-39.953806,"eighty":-20.967665,"marketCap":2416751599},{"date":"2023-03-17","current":-22.814647,"twenty":-50.628165,"median":-39.81605,"eighty":-20.881589,"marketCap":2929925462},{"date":"2023-03-24","current":-22.508745,"twenty":-50.547877,"median":-39.758269,"eighty":-20.937818,"marketCap":2890640524},{"date":"2023-03-31","current":-24.884826,"twenty":-50.538628,"median":-39.648544,"eighty":-20.967665,"marketCap":3195783993},{"date":"2023-04-06","current":-22.608341,"twenty":-50.398102,"median":-39.410762,"eighty":-20.985573,"marketCap":2903430969},{"date":"2023-04-14","current":-23.753697,"twenty":-50.260054,"median":-39.321908,"eighty":-21.029355,"marketCap":3050521084},{"date":"2023-04-21","current":-24.273021,"twenty":-50.211876,"median":-39.198908,"eighty":-21.041663,"marketCap":3117214118},{"date":"2023-04-28","current":-22.053448,"twenty":-50.10983,"median":-39.086878,"eighty":-21.052864,"marketCap":2832169920},{"date":"2023-05-05","current":-20.085339,"twenty":-50.030853,"median":-39.045525,"eighty":-21.029355,"marketCap":2579419472},{"date":"2023-05-12","current":-21.254175,"twenty":-50.011348,"median":-38.97946,"eighty":-20.981096,"marketCap":2729524925},{"date":"2023-05-19","current":-21.074906,"twenty":-49.936988,"median":-38.858126,"eighty":-20.935287,"marketCap":2706502616},{"date":"2023-05-26","current":-18.98821,"twenty":-49.739821,"median":-38.781427,"eighty":-20.865452,"marketCap":2438522942},{"date":"2023-06-02","current":-23.7011,"twenty":-49.634889,"median":-38.748697,"eighty":-20.83367,"marketCap":2555476271},{"date":"2023-06-09","current":-19.16437,"twenty":-49.587066,"median":-38.685442,"eighty":-20.780404,"marketCap":2066321490},{"date":"2023-06-16","current":-19.591955,"twenty":-49.518553,"median":-38.668128,"eighty":-20.758997,"marketCap":2112424156},{"date":"2023-06-23","current":-18.642716,"twenty":-49.490829,"median":-38.652026,"eighty":-20.740419,"marketCap":2010076237},{"date":"2023-06-30","current":-18.830853,"twenty":-49.425691,"median":-38.650282,"eighty":-20.728887,"marketCap":2030361410},{"date":"2023-07-07","current":-18.753888,"twenty":-49.321753,"median":-38.534252,"eighty":-20.640309,"marketCap":2022062930},{"date":"2023-07-14","current":-21.12271,"twenty":-49.135663,"median":-38.486364,"eighty":-20.586625,"marketCap":2277471700},{"date":"2023-07-21","current":-20.626711,"twenty":-49.077653,"median":-38.375503,"eighty":-20.595005,"marketCap":2223992607},{"date":"2023-07-28","current":-21.105606,"twenty":-49.061015,"median":-38.330676,"eighty":-20.595005,"marketCap":2275627593},{"date":"2023-08-04","current":-20.883262,"twenty":-49.007339,"median":-38.158206,"eighty":-20.613914,"marketCap":2251654207},{"date":"2023-08-11","current":-20.549746,"twenty":-48.954208,"median":-37.988814,"eighty":-20.586625,"marketCap":2215694127},{"date":"2023-08-18","current":-20.01954,"twenty":-48.941266,"median":-37.845067,"eighty":-20.541194,"marketCap":2158526822},{"date":"2023-08-25","current":-20.66947,"twenty":-48.894876,"median":-37.770349,"eighty":-20.506987,"marketCap":2228602874},{"date":"2023-09-01","current":-25.511357,"twenty":-48.832826,"median":-37.755599,"eighty":-20.541194,"marketCap":2375209352},{"date":"2023-09-07","current":-24.043412,"twenty":-48.807682,"median":-37.686377,"eighty":-20.560008,"marketCap":2238537799},{"date":"2023-09-14","current":-23.412009,"twenty":-48.750972,"median":-37.671633,"eighty":-20.577111,"marketCap":2179751687},{"date":"2023-09-22","current":-22.590183,"twenty":-48.595885,"median":-37.578261,"eighty":-20.58462,"marketCap":2103236431},{"date":"2023-09-28","current":-22.048981,"twenty":-48.583225,"median":-37.547623,"eighty":-20.587293,"marketCap":2052848336},{"date":"2023-10-05","current":-21.978825,"twenty":-48.576545,"median":-37.531928,"eighty":-20.595005,"marketCap":2046316545},{"date":"2023-10-11","current":-21.497757,"twenty":-48.562801,"median":-37.500901,"eighty":-20.605423,"marketCap":2001527127},{"date":"2023-10-20","current":-20.345196,"twenty":-48.534663,"median":-37.448341,"eighty":-20.589221,"marketCap":1894219146},{"date":"2023-10-27","current":-19.894194,"twenty":-48.514606,"median":-37.410785,"eighty":-20.580532,"marketCap":1852229066},{"date":"2023-11-03","current":-20.485508,"twenty":-48.433814,"median":-37.299311,"eighty":-20.506205,"marketCap":1907282726},{"date":"2023-11-10","current":-20.746087,"twenty":-48.370598,"median":-37.219715,"eighty":-20.506987,"marketCap":1931543661},{"date":"2023-11-17","current":-21.217133,"twenty":-48.32991,"median":-37.120374,"eighty":-20.524091,"marketCap":1975399966},{"date":"2023-11-24","current":-21.858558,"twenty":-48.320008,"median":-37.057747,"eighty":-20.549746,"marketCap":2035119191},{"date":"2023-11-30","current":-22.048981,"twenty":-48.252059,"median":-36.968279,"eighty":-20.57027,"marketCap":2052848336},{"date":"2023-12-07","current":-26.625426,"twenty":-48.121131,"median":-36.925787,"eighty":-20.578821,"marketCap":2015198621},{"date":"2023-12-15","current":-28.276615,"twenty":-48.00719,"median":-36.911135,"eighty":-20.582242,"marketCap":2140172179},{"date":"2024-01-05","current":-26.103359,"twenty":-47.918569,"median":-36.904212,"eighty":-20.585288,"marketCap":1975684923},{"date":"2024-01-12","current":-31.117632,"twenty":-47.865829,"median":-36.842529,"eighty":-20.591149,"marketCap":2355200212},{"date":"2024-01-19","current":-31.627558,"twenty":-47.844972,"median":-36.829603,"eighty":-20.601178,"marketCap":2393794988},{"date":"2024-01-26","current":-29.053645,"twenty":-47.78321,"median":-36.766338,"eighty":-20.619869,"marketCap":2198983265},{"date":"2024-02-02","current":-29.32075,"twenty":-47.731847,"median":-36.504107,"eighty":-20.628421,"marketCap":2219199576},{"date":"2024-02-09","current":-29.393596,"twenty":-47.672575,"median":-36.388531,"eighty":-20.635263,"marketCap":2224713115},{"date":"2024-02-16","current":-29.733547,"twenty":-47.618326,"median":-36.095963,"eighty":-20.635379,"marketCap":2250442965},{"date":"2024-02-23","current":-28.10664,"twenty":-47.602066,"median":-35.89466,"eighty":-20.635842,"marketCap":2127307254},{"date":"2024-03-01","current":-29.332891,"twenty":-47.570415,"median":-35.678665,"eighty":-20.651153,"marketCap":2220118499},{"date":"2024-03-08","current":-29.55143,"twenty":-47.518149,"median":-35.35785,"eighty":-20.660918,"marketCap":2236659117},{"date":"2024-03-15","current":-26.009561,"twenty":-47.49129,"median":-35.24315,"eighty":-20.664708,"marketCap":2126463652},{"date":"2024-03-22","current":-25.786705,"twenty":-47.380514,"median":-34.925503,"eighty":-20.66947,"marketCap":2108243640},{"date":"2024-03-28","current":-24.935846,"twenty":-47.342533,"median":-34.589879,"eighty":-20.66947,"marketCap":2038679948},{"date":"2024-04-05","current":-25.071983,"twenty":-47.312176,"median":-34.414946,"eighty":-20.689994,"marketCap":2049810139},{"date":"2024-04-12","current":-25.888808,"twenty":-47.269427,"median":-33.423363,"eighty":-20.697474,"marketCap":2116591283},{"date":"2024-04-19","current":-23.631195,"twenty":-47.158961,"median":-33.184171,"eighty":-20.697474,"marketCap":1932015619},{"date":"2024-04-26","current":-22.916473,"twenty":-46.951231,"median":-33.003753,"eighty":-20.698257,"marketCap":1873582118},{"date":"2024-05-03","current":-23.897861,"twenty":-46.656905,"median":-32.649248,"eighty":-20.698257,"marketCap":1953817432},{"date":"2024-05-10","current":-23.114516,"twenty":-46.598159,"median":-32.247909,"eighty":-20.698257,"marketCap":1889773514},{"date":"2024-05-17","current":-24.517522,"twenty":-46.43348,"median":-31.759443,"eighty":-20.698257,"marketCap":2004479038},{"date":"2024-05-24","current":-22.904066,"twenty":-46.181838,"median":-31.451512,"eighty":-20.698257,"marketCap":1872567685},{"date":"2024-05-31","current":-20.986625,"twenty":-46.068748,"median":-31.128449,"eighty":-20.698257,"marketCap":1715803469},{"date":"2024-06-07","current":-20.224161,"twenty":-45.830813,"median":-30.643949,"eighty":-20.66395,"marketCap":1892880316},{"date":"2024-06-14","current":-21.429439,"twenty":-45.725202,"median":-30.31849,"eighty":-20.645029,"marketCap":2005688335},{"date":"2024-06-21","current":-21.357939,"twenty":-45.671397,"median":-29.967092,"eighty":-20.641966,"marketCap":1998996334},{"date":"2024-06-28","current":-23.247571,"twenty":-45.51108,"median":-29.932669,"eighty":-20.635726,"marketCap":2175856364},{"date":"2024-07-05","current":-22.542789,"twenty":-45.42729,"median":-29.794252,"eighty":-20.635726,"marketCap":2109892353},{"date":"2024-07-12","current":-21.439653,"twenty":-45.27192,"median":-29.668005,"eighty":-20.635726,"marketCap":2006644335},{"date":"2024-07-15","current":-21.807365,"twenty":-45.165128,"median":-29.6527,"eighty":-20.635726,"marketCap":2041060341},{"date":"2024-08-02","current":-20.438659,"twenty":-44.67116,"median":-29.473821,"eighty":-20.619869,"marketCap":1912956320},{"date":"2024-08-09","current":-18.937169,"twenty":-44.592228,"median":-29.326821,"eighty":-20.554877,"marketCap":1772424296},{"date":"2024-08-16","current":-19.846234,"twenty":-44.342086,"median":-29.065787,"eighty":-20.488395,"marketCap":1857508310},{"date":"2024-08-23","current":-19.366166,"twenty":-44.293477,"median":-28.968658,"eighty":-20.439367,"marketCap":1812576303},{"date":"2024-08-30","current":-20.193518,"twenty":-44.126836,"median":-28.878841,"eighty":-20.396729,"marketCap":1890012316},{"date":"2024-09-06","current":-20.851386,"twenty":-44.070828,"median":-28.815003,"eighty":-20.350301,"marketCap":1731811836},{"date":"2024-09-13","current":-19.495653,"twenty":-43.902513,"median":-28.750118,"eighty":-20.261779,"marketCap":1619211496},{"date":"2024-09-20","current":-20.358392,"twenty":-43.724824,"median":-28.493474,"eighty":-20.244564,"marketCap":1690866258},{"date":"2024-09-27","current":-20.324779,"twenty":-43.52784,"median":-28.425739,"eighty":-20.226358,"marketCap":1688074514},{"date":"2024-10-04","current":-19.753355,"twenty":-43.367535,"median":-28.373476,"eighty":-20.209123,"marketCap":1640614867},{"date":"2024-10-11","current":-20.30237,"twenty":-43.311657,"median":-28.264591,"eighty":-20.195561,"marketCap":1686213351},{"date":"2024-10-18","current":-21.030656,"twenty":-43.248031,"median":-28.136018,"eighty":-20.195561,"marketCap":1746701137},{"date":"2024-10-25","current":-20.078282,"twenty":-43.248031,"median":-28.049113,"eighty":-20.145499,"marketCap":1667601725},{"date":"2024-10-31","current":-20.649706,"twenty":-43.248031,"median":-27.765641,"eighty":-20.132647,"marketCap":1715061372},{"date":"2024-11-08","current":-22.688907,"twenty":-43.252213,"median":-27.636067,"eighty":-20.132233,"marketCap":1884427173},{"date":"2024-11-15","current":-21.960621,"twenty":-43.252213,"median":-27.448241,"eighty":-20.132233,"marketCap":1823939387},{"date":"2024-11-22","current":-22.229527,"twenty":-43.231304,"median":-27.106738,"eighty":-20.132233,"marketCap":1846273338},{"date":"2024-11-29","current":-25.707412,"twenty":-43.145724,"median":-26.876224,"eighty":-20.132233,"marketCap":1914893729},{"date":"2024-12-06","current":-25.40483,"twenty":-43.145724,"median":-26.625426,"eighty":-20.132233,"marketCap":1892354961},{"date":"2024-12-13","current":-24.521289,"twenty":-43.145724,"median":-26.466422,"eighty":-20.132233,"marketCap":1826541758},{"date":"2024-12-20","current":-22.572657,"twenty":-43.145724,"median":-26.327469,"eighty":-20.132233,"marketCap":1681392092},{"date":"2024-12-27","current":-22.173248,"twenty":-43.145724,"median":-26.203648,"eighty":-20.132233,"marketCap":1651640919},{"date":"2025-01-03","current":-21.785943,"twenty":-43.145724,"median":-26.12294,"eighty":-20.132233,"marketCap":1622791296},{"date":"2025-01-10","current":-21.434947,"twenty":-43.151859,"median":-25.994723,"eighty":-20.130744,"marketCap":1596646325},{"date":"2025-01-17","current":-22.584761,"twenty":-43.151859,"median":-25.832017,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-24","current":-22.584761,"twenty":-43.151859,"median":-25.722549,"eighty":-20.130744,"marketCap":1682293643},{"date":"2025-01-31","current":-22.330591,"twenty":-43.151859,"median":-25.688138,"eighty":-20.130744,"marketCap":1663361078},{"date":"2025-02-07","current":-23.032583,"twenty":-43.151859,"median":-25.544418,"eighty":-20.130744,"marketCap":1715651020},{"date":"2025-02-14","current":-23.601438,"twenty":-43.151859,"median":-25.410136,"eighty":-20.130744,"marketCap":1758023904},{"date":"2025-02-21","current":-22.149042,"twenty":-43.151859,"median":-25.353801,"eighty":-20.130744,"marketCap":1649837817},{"date":"2025-02-28","current":-21.229191,"twenty":-43.151859,"median":-25.248903,"eighty":-20.130744,"marketCap":1581319962},{"date":"2025-03-07","current":-20.902402,"twenty":-43.157994,"median":-25.114351,"eighty":-20.129255,"marketCap":1556978093},{"date":"2025-03-14","current":-25.841364,"twenty":-43.157994,"median":-25.015259,"eighty":-20.118618,"marketCap":1407320673},{"date":"2025-03-21","current":-31.526661,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1716941957},{"date":"2025-03-28","current":-31.810986,"twenty":-43.157994,"median":-25.094673,"eighty":-20.118618,"marketCap":1732426315},{"date":"2025-04-04","current":-28.415807,"twenty":-43.157994,"median":-25.140052,"eighty":-20.118618,"marketCap":1547524873},{"date":"2025-04-11","current":-25.672904,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1398146368},{"date":"2025-04-17","current":-25.238054,"twenty":-43.151859,"median":-25.115856,"eighty":-20.120859,"marketCap":1374464410},{"date":"2025-04-25","current":-26.22483,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1428204238},{"date":"2025-05-02","current":-26.007405,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1416363259},{"date":"2025-05-09","current":-26.208105,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1427293394},{"date":"2025-05-16","current":-28.064582,"twenty":-43.157994,"median":-25.054079,"eighty":-20.118618,"marketCap":1528397138},{"date":"2025-05-23","current":-26.826931,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1460994642},{"date":"2025-05-30","current":-40.212905,"twenty":-43.110374,"median":-25.054079,"eighty":-20.118618,"marketCap":1483896395},{"date":"2025-06-06","current":-38.417271,"twenty":-42.89345,"median":-25.054079,"eighty":-20.118618,"marketCap":1417635735},{"date":"2025-06-13","current":-37.443101,"twenty":-42.85482,"median":-25.054079,"eighty":-20.118618,"marketCap":1381687885},{"date":"2025-06-20","current":-35.644634,"twenty":-42.692819,"median":-25.045717,"eighty":-20.116377,"marketCap":1315322623},{"date":"2025-06-27","current":-37.218293,"twenty":-42.4845,"median":-25.045717,"eighty":-20.116377,"marketCap":1373392227},{"date":"2025-07-03","current":-39.940973,"twenty":-42.385562,"median":-25.045717,"eighty":-20.116377,"marketCap":1473861860},{"date":"2025-07-11","current":-39.516335,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1458192284},{"date":"2025-07-18","current":-36.593825,"twenty":-42.275719,"median":-25.045717,"eighty":-20.116377,"marketCap":1350348733},{"date":"2025-07-25","current":-36.743697,"twenty":-42.001222,"median":-25.045717,"eighty":-20.116377,"marketCap":1355879172},{"date":"2025-08-01","current":-40.265697,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1485844477},{"date":"2025-08-08","current":-38.941825,"twenty":-41.552011,"median":-25.045717,"eighty":-20.116377,"marketCap":1436992270},{"date":"2025-08-15","current":-38.667059,"twenty":-41.27534,"median":-25.045717,"eighty":-20.116377,"marketCap":1426853133},{"date":"2025-08-22","current":-39.441399,"twenty":-41.020287,"median":-25.045717,"eighty":-20.116377,"marketCap":1455427065},{"date":"2025-08-29","current":-42.263994,"twenty":-40.940123,"median":-25.045717,"eighty":-20.116377,"marketCap":1559583657},{"date":"2025-09-05","current":-111.301894,"twenty":-40.946258,"median":-25.037354,"eighty":-20.114136,"marketCap":1545092897},{"date":"2025-09-12","current":-111.369065,"twenty":-41.159237,"median":-25.045717,"eighty":-20.116377,"marketCap":1546025361},{"date":"2025-09-19","current":-110.361504,"twenty":-41.502219,"median":-25.045717,"eighty":-20.116377,"marketCap":1532038401},{"date":"2025-09-26","current":-108.816577,"twenty":-41.627318,"median":-25.045717,"eighty":-20.116377,"marketCap":1510591728},{"date":"2025-10-03","current":-110.630187,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1535768257},{"date":"2025-10-10","current":-109.824138,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1524578689},{"date":"2025-10-17","current":-105.659553,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1466765919},{"date":"2025-10-24","current":-107.540334,"twenty":-41.713376,"median":-25.045717,"eighty":-20.116377,"marketCap":1492874912},{"date":"2025-10-31","current":-105.793895,"twenty":-41.746269,"median":-25.045717,"eighty":-20.116377,"marketCap":1468630847},{"date":"2025-11-07","current":-101.562139,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1409885613},{"date":"2025-11-14","current":-104.719163,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1453711422},{"date":"2025-11-21","current":-98.740968,"twenty":-41.812397,"median":-25.045717,"eighty":-20.116377,"marketCap":1370722124},{"date":"2025-11-28","current":6.997444,"twenty":-41.746269,"median":-24.978468,"eighty":-20.091839,"marketCap":1065227860},{"date":"2025-12-05","current":7.219871,"twenty":-41.569584,"median":-24.845699,"eighty":-20.051536,"marketCap":1099088196},{"date":"2025-12-12","current":7.833049,"twenty":-41.149298,"median":-24.524361,"eighty":-20.010479,"marketCap":1192432905},{"date":"2025-12-19","current":7.79698,"twenty":-40.783904,"median":-24.456235,"eighty":-19.933106,"marketCap":1186942040},{"date":"2025-12-26","current":7.839061,"twenty":-40.638471,"median":-24.290539,"eighty":-19.921421,"marketCap":1193348049},{"date":"2026-01-02","current":7.881142,"twenty":-40.445544,"median":-24.213538,"eighty":-19.883804,"marketCap":1199754059},{"date":"2026-01-09","current":7.616633,"twenty":-40.245714,"median":-24.133436,"eighty":-19.850083,"marketCap":1159487714},{"date":"2026-01-16","current":7.105652,"twenty":-40.140803,"median":-24.036721,"eighty":-19.806911,"marketCap":1081700456},{"date":"2026-01-23","current":6.738947,"twenty":-40.000922,"median":-23.900481,"eighty":-19.757821,"marketCap":1025876659},{"date":"2026-01-30","current":6.318139,"twenty":-39.844633,"median":-23.836174,"eighty":-19.718173,"marketCap":961816564},{"date":"2026-02-06","current":4.749124,"twenty":-39.429144,"median":-23.74822,"eighty":-19.674843,"marketCap":722963925},{"date":"2026-02-13","current":4.075831,"twenty":-39.135469,"median":-23.649661,"eighty":-19.608912,"marketCap":620467774},{"date":"2026-02-20","current":4.021727,"twenty":-38.923318,"median":-23.601935,"eighty":-19.561129,"marketCap":612231476},{"date":"2026-02-27","current":4.256177,"twenty":-38.673097,"median":-23.492961,"eighty":-19.508534,"marketCap":647922100},{"date":"2026-03-06","current":4.664962,"twenty":-38.60711,"median":-23.396809,"eighty":-19.489511,"marketCap":710151906},{"date":"2026-03-13","current":3.826831,"twenty":-38.317356,"median":-23.305813,"eighty":-19.445457,"marketCap":665309840},{"date":"2026-03-20","current":3.358288,"twenty":-37.997629,"median":-23.223191,"eighty":-19.406656,"marketCap":583851876},{"date":"2026-03-27","current":3.07113,"twenty":-37.726969,"median":-23.142007,"eighty":-19.330546,"marketCap":533928310},{"date":"2026-04-02","current":3.075998,"twenty":-37.531928,"median":-23.103807,"eighty":-19.288759,"marketCap":534774472},{"date":"2026-04-10","current":2.95432,"twenty":-37.33152,"median":-23.026783,"eighty":-19.228348,"marketCap":513620418},{"date":"2026-04-17","current":3.119801,"twenty":-37.141321,"median":-22.922472,"eighty":-19.200424,"marketCap":542389931},{"date":"2026-04-24","current":2.998124,"twenty":-36.968415,"median":-22.886122,"eighty":-19.150518,"marketCap":521235878},{"date":"2026-05-01","current":3.236611,"twenty":-36.792556,"median":-22.796862,"eighty":-19.059356,"marketCap":562697823},{"date":"2026-05-08","current":3.60651,"twenty":-36.546214,"median":-22.703577,"eighty":-18.989041,"marketCap":627006145},{"date":"2026-05-15","current":2.967148,"twenty":-36.114067,"median":-22.620757,"eighty":-18.890004,"marketCap":515850488},{"date":"2026-05-22","current":3.10823,"twenty":-35.890938,"median":-22.561376,"eighty":-18.847957,"marketCap":540378298},{"date":"2026-05-29","current":3.010498,"twenty":-35.390059,"median":-22.540072,"eighty":-18.78733,"marketCap":573791883},{"date":"2026-06-05","current":3.84405,"twenty":-34.84372,"median":-22.428622,"eighty":-18.581645,"marketCap":732664367},{"date":"2026-06-12","current":3.548665,"twenty":-32.834795,"median":-22.336643,"eighty":-18.476527,"marketCap":676364895},{"date":"2026-06-18","current":3.487969,"twenty":-32.200072,"median":-22.276208,"eighty":-18.281834,"marketCap":664796510},{"date":"2026-06-26","current":3.463691,"twenty":-31.676123,"median":-22.229527,"eighty":-18.139398,"marketCap":660169156},{"date":"2026-07-02","current":4.058507,"twenty":-31.506957,"median":-22.173248,"eighty":-18.004593,"marketCap":773539326},{"date":"2026-07-10","current":4.232501,"twenty":-31.379147,"median":-22.100628,"eighty":-17.925594,"marketCap":806702029},{"date":"2026-07-17","current":4.309382,"twenty":-30.85814,"median":-22.017878,"eighty":-17.790437,"marketCap":821355317},{"date":"2026-07-24","current":3.492016,"twenty":-30.583371,"median":-21.935122,"eighty":-17.680267,"marketCap":665567735},{"date":"2026-07-31","current":4.196084,"twenty":-30.20705,"median":-21.898647,"eighty":-17.533486,"marketCap":799760999},{"date":"2026-08-07","current":4.491469,"twenty":-29.939946,"median":-21.843368,"eighty":-17.408164,"marketCap":856060471},{"date":"2026-08-14","current":4.892059,"twenty":-29.794252,"median":-21.785943,"eighty":-17.253175,"marketCap":932411810},{"date":"2026-08-21","current":4.904198,"twenty":-29.6527,"median":-21.707843,"eighty":-16.923368,"marketCap":934725487},{"date":"2026-08-28","current":5.299253,"twenty":-29.522867,"median":-21.601223,"eighty":-16.727101,"marketCap":983255111},{"date":"2026-09-04","current":5.91603,"twenty":-29.332891,"median":-21.539711,"eighty":-16.640261,"marketCap":1097695730},{"date":"2026-09-11","current":5.769178,"twenty":-29.150774,"median":-21.490433,"eighty":-16.485271,"marketCap":1070447963},{"date":"2026-09-18","current":6.058686,"twenty":-29.002076,"median":-21.4373,"eighty":-16.309146,"marketCap":1124164988},{"date":"2026-09-25","current":6.27267,"twenty":-28.907952,"median":-21.397735,"eighty":-16.110204,"marketCap":1163868876},{"date":"2026-10-02","current":6.537004,"twenty":-28.831325,"median":-21.327334,"eighty":-16.042428,"marketCap":1212914856}],"updateTime":1791049233743},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PD\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645307797","title":"PagerDuty Appoints Eric Prengel as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2645307797","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645307797?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:05","pubTimestamp":1782158700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA1TLWZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1169590202.USD","PD","BK4023","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643759930","title":"How Investors Are Reacting To Agilent Technologies (A) Expanding PD-L1 Test Use And Launching New AI Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2643759930","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643759930?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:28","pubTimestamp":1781605729,"startTime":"0","endTime":"0","summary":"Earlier in June 2026, Agilent Technologies announced FDA approval to expand use of its PD-L1 IHC 22C3 pharmDx diagnostic on the Dako Omnis platform across multiple additional cancer types, while also revealing a collaboration with OpenAI and Boston Consulting Group to accelerate artificial intelligence deployment in its instruments, software, and services.\nThis combination of broader companion diagnostic use for KEYTRUDA and a company-wide push into applied AI could reshape how Agilent...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/154924-main-header/1756254020530","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/154924-main-header/1756254020530"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/how-investors-are-reacting-to-agilent-technologies-a-expandi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-a/agilent-technologies/news/how-investors-are-reacting-to-agilent-technologies-a-expandi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1169589451.USD","BK4585","IE00BN0W2T93.GBP","BK4211","LU2089279066.USD","CHAT","LU1165135440.EUR","LU2413666426.HKD","BK4588","LU2092937221.SGD","BK4121","LU2413666699.HKD","AGIX","LU1169590202.USD","LU0347712357.USD","LU1721428933.USD","AIPO","LU1543694498.USD","ISBC","BK4567","LU2041044095.USD","LU2229751404.USD","ARTY","IE00BN0W2W23.USD","BK4023","A","PD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643438205","title":"ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643438205","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643438205?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:45","pubTimestamp":1781527500,"startTime":"0","endTime":"0","summary":"The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo reported for the first time as an oral presentation at ENDO 2026  Single tablet EB613 a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3311797/0/en/ENDO-2026-Oral-Presentation-Highlights-Comparative-Clinical-Data-for-Entera-s-Breakthrough-Single-Tablet-EB613-First-in-Class-Oral-PTH-1-34-Anabolic-for-Osteoporosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AUC","BK4123","PTH","ENTX","PD","BK4183","BK4218","LU1169590202.USD","BK4181","LU1169589451.USD","ENDO","BK4023","BK4139","PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643624463","title":"Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643624463","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643624463?lang=en_us&edition=fundamental","pubTime":"2026-06-14 22:00","pubTimestamp":1781445600,"startTime":"0","endTime":"0","summary":"– Lorundrostat was associated with significant reductions in heart failure risk biomarkers in a proteomic analysis of data from participants with uncontrolled hypertension – – Coordinated reductions i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/14/3311447/0/en/Mineralys-Therapeutics-Presents-Late-Breaking-Data-on-Lorundrostat-and-Heart-Failure-Risk-Biomarkers-at-The-Endocrine-Society-Annual-Meeting-ENDO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0072461881.USD","ENDO","LU0320765646.SGD","LU0300736492.USD","LU1829250122.USD","BP","LU0300736062.USD","BK4023","LU0006061336.USD","BK4585","BK4007","LU0162691827.USD","BPH","BK4201","ARB","LENZ","HF","BK4588","LU1162221912.USD","LU1169590202.USD","BK4183","PD","LU1169589451.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116728399","title":"SIMCERE PHARMA Receives NMPA Approval for Clinical Trial of SIM0689, a Dual-Target Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=1116728399","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116728399?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:10","pubTimestamp":1781269818,"startTime":"0","endTime":"0","summary":"SIMCERE PHARMA (HKEX: 02096) has announced that its independently developed bispecific antibody, SIM0689, targeting PD-1 and VEGF, has received a drug clinical trial approval notice from China's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","PD","02096","LU1169589451.USD","LU1169590202.USD","BK4023","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642629555","title":"Simcere Wins NMPA Green Light for PD-1/VEGF Bispecific Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2642629555","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642629555?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:09","pubTimestamp":1781269770,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group Limited ( ($HK:2096) ) has issued an update. Simcere Pharmaceutical Group Limited has received clinical trial approval...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/simcere-wins-nmpa-green-light-for-pd-1-vegf-bispecific-cancer-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/simcere-wins-nmpa-green-light-for-pd-1-vegf-bispecific-cancer-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","LU1169590202.USD","PD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281948","title":"PagerDuty survey finds 66% of office professionals use unauthorized AI tools at work","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642281948?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:00","pubTimestamp":1781179246,"startTime":"0","endTime":"0","summary":"PagerDuty published a survey showing 66% of office professionals used unauthorized AI tools at work, highlighting widening governance gaps.Data leakage risk emerged: 88% shared work information with public AI tools; 31% shared financial information or confidential documents.Workforce impact signaled: 77% said AI restrictions limit career growth; 75% would consider job moves for better AI skills development.Compliance appeared uneven: 53% received informal direction to stop; 48% faced formal consequences; 81% perceived different AI rules for leadership.Confidence outpaced oversight: 72% said they know AI better than their tech teams, rising to 80% at companies with revenue above USD 1 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL8HKXR6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU1169590202.USD","PD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642286911","title":"Press Release: AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2642286911","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642286911?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:00","pubTimestamp":1781175600,"startTime":"0","endTime":"0","summary":"-- Grant supports extension of Part 1 of Phase 2 VacSYn trial of ACI-7104. -- Planned extension of Part 1 will assess long-term safety and efficacy of. Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: \"We are honored to receive this grant from The Vijay and Marie Goradia Charitable Foundation. ACI-7104 is showing considerable promise in clinical testing. I would like to thank Vijay and Marie Goradia both for their generous contribution and for their recognition of the potential of ACI-7104 as AC Immune continues to advance towards precision prevention of neurodegenerative diseases, including PD.\". Martin Zügel, MD, interim CEO designate of AC Immune and Chair of the Board of Directors, commented: \"We thank The Vijay and Marie Goradia Charitable Foundation for this grant in support of our efforts to develop ACI-7104 in early-stage PD. The grant will significantly impact the extension of Part 1 of the VacSYn trial and enable us to generate vital long-term data on the use of the produc","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","BK4022","BK4139","R","LU1169590202.USD","BK4113","ACI","BK4232","BK4023","PD","ACIU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130924236","title":"Southwest Securities: Post-PD-(L)1 Treatment Resistance Poses Significant Challenge, 2026 to See High Concentration of Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1130924236","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130924236?lang=en_us&edition=fundamental","pubTime":"2026-06-11 16:43","pubTimestamp":1781167390,"startTime":"0","endTime":"0","summary":"Southwest Securities has released a research report stating that PD-(L)1 inhibitors are undergoing a critical transition from \"widespread adoption\" to \"post-treatment iteration.\" In the post-PD-1...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0210528500.USD","BK0183","BK4588","BK0276","BK0188","600369","BK4107","BK0028","LU2487616109.SGD","PD","L","LU1169589451.USD","LU1169590202.USD","BK0012","BK4023","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642327964","title":"PagerDuty announces Ingram Micro as authorized distributor in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2642327964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642327964?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:05","pubTimestamp":1780956347,"startTime":"0","endTime":"0","summary":"PagerDuty (PD) announced Ingram Micro (INGM) as its first and only authorised distributor in Australia, marking a significant expansion of PagerDut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pagerduty-announces-ingram-micro-as-authorized-distributor-in-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pagerduty-announces-ingram-micro-as-authorized-distributor-in-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INGM","LU1169589451.USD","BK4140","BK4023","PD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642321574","title":"PagerDuty names Ingram Micro exclusive distributor in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2642321574","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642321574?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:00","pubTimestamp":1780956018,"startTime":"0","endTime":"0","summary":"PagerDuty named Ingram Micro its exclusive authorized distributor in Australia, expanding its regional channel strategy.Deal adds PagerDuty to Ingram Micro’s Australia line card and cloud marketplaces, aimed at accelerating Operations Cloud adoption.Partnership targets faster procurement and partner enablement for enterprise customers, with integrations across observability, ITSM, security, DevOps.Companies plan joint partner recruitment, enablement, and solution bundling to speed deployments and improve customer time-to-value.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL5S4RbP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4140","LU1169589451.USD","BK4023","PD","LU1169590202.USD","INGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642432946","title":"PagerDuty Expands Australia Footprint With Exclusive Distribution Agreement With Ingram Micro","url":"https://stock-news.laohu8.com/highlight/detail?id=2642432946","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642432946?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:00","pubTimestamp":1780956000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA21CHKY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1169589451.USD","PD","BK4023","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641481906","title":"MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2641481906","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641481906?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:00","pubTimestamp":1780920000,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., June  08, 2026  (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3308039/7767/en/MediciNova-Receives-Notice-of-Allowance-for-New-Patent-Covering-Use-of-MN-166-in-Combination-with-Anti-PD-1-Immune-Checkpoint-Inhibitor-for-Glioblastoma-Treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550221.USD","LU0912757837.SGD","LU0528227936.USD","LU0106261372.USD","LU1162221912.USD","LU0158827948.USD","LU0557290698.USD","LU2023251221.USD","LU1791710582.SGD","BK4504","LU2264538146.SGD","BK4023","LU0210528500.USD","LU0971096721.USD","PD","LU2028103732.USD","IE00BKVL7J92.USD","BK4581","BK4516","LU2487616109.SGD","LU0053666078.USD","LU2347655156.SGD","LU1989772923.USD","LU0320765646.SGD","MNOV","BK4534","LU0106831901.USD","LU1244550577.SGD","LU0225283273.USD","LU0158827781.USD","LU1064131342.USD","BK4588","LU1363072403.SGD","LU0234570918.USD","LU1732800096.USD","LU2111349929.HKD","LU1668664300.SGD","LU1720051017.SGD","LU1169589451.USD","LU0267386448.USD","BK4585","IE00BZ1G4Q59.USD","LU1244550494.USD","LU0390134368.USD","ARDS","LU2089283258.USD","LU1988902786.USD","LU2089284900.SGD","LU2357305700.SGD","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641123920","title":"Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2641123920","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641123920?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:32","pubTimestamp":1780702320,"startTime":"0","endTime":"0","summary":"Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a once-daily oral pill for the treatment of obesity and ove","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/05/3307661/0/en/Hengrui-Pharma-and-Kailera-Therapeutics-Present-Ribupatide-Clinical-Data-at-ADA-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","PK","BK4123","LU1169590202.USD","AUC","BK4023","LU1169589451.USD","KLRA","BK4181","BK4139","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641110164","title":"Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2641110164","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641110164?lang=en_us&edition=fundamental","pubTime":"2026-06-05 20:00","pubTimestamp":1780660800,"startTime":"0","endTime":"0","summary":"Phase 4 ELEVATE-PD interim data from the entire study population (n=214) continue to show clinically meaningful, consistent benefits of CREXONT across all prior treatment groupsSubstantial increases i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/05/3307337/0/en/Amneal-Announces-Full-Study-Population-Interim-Phase-4-ELEVATE-PD-Results-Reinforcing-Previously-Reported-Benefits-of-CREXONT-in-Parkinson-s-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1169589451.USD","CNS","BK4023","PD","BK4135","LU1169590202.USD","BK4116","CD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904881","title":"PagerDuty price target raised to $10 from $7 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904881?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:08","pubTimestamp":1780488520,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on PagerDuty (PD) to $10 from $7 and keeps an Equal Weight rating on the shares. Following Q1 results...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pagerduty-price-target-raised-to-10-from-7-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pagerduty-price-target-raised-to-10-from-7-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1169589451.USD","LU0006306889.USD","LU2089284900.SGD","LU0158827948.USD","LU0053666078.USD","BK4023","LU0234570918.USD","LU1244550494.USD","LU0098860793.USD","LU0158827781.USD","LU1244550221.USD","LU1732799900.SGD","PD","LU2357305700.SGD","LU0106261372.USD","LU2487616109.SGD","LU1791710400.SGD","LU1720051108.HKD","LU2347655156.SGD","LU2023251221.USD","LU2271345857.HKD","LU2028103732.USD","BK4534","BK4581","LU1244550577.SGD","LU0971096721.USD","LU1668664300.SGD","LU1064131342.USD","LU2111349929.HKD","LU2264538146.SGD","LU1791710582.SGD","LU1720051017.SGD","LU2089283258.USD","LU1363072403.SGD","LU0557290698.USD","LU2133065610.SGD","LU1989772923.USD","BK4585","LU0106831901.USD","BK4516","BK4588","LU0210528500.USD","LU0795875086.SGD","LU0314104364.USD","LU1162221912.USD","LU0320765646.SGD","BK4504","LU0267386448.USD","LU0528227936.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640090944","title":"TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640090944","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640090944?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:30","pubTimestamp":1780486200,"startTime":"0","endTime":"0","summary":"Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line Phase 3 data expected year-end 2026 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/03/3305943/8790/en/TG-Therapeutics-Announces-Positive-Results-from-Phase-1-Trial-Evaluating-Subcutaneous-BRIUMVI-ublituximab-xiiy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","LU0971096721.USD","ALT","LU0882574139.USD","PK","LU0098860793.USD","LU0106831901.USD","LU1074936037.SGD","LU1732799900.SGD","LU1363072403.SGD","BK4588","LU1244550577.SGD","LU0390134368.USD","LU1162221912.USD","LU0210528500.USD","LU0795875169.SGD","BK4181","LU0106261372.USD","BK4153","LU1548497426.USD","TGTX","BK4581","BK4585","HCP","LU1244550221.USD","BK4023","LU0006306889.USD","LU1988902786.USD","LU1064131342.USD","LU0158827781.USD","LU1720051108.HKD","BK4599","LU2271345857.HKD","LU1169589451.USD","LU2264538146.SGD","BK4156","IE00BZ1G4Q59.USD","BK4090","PD","LU1169590202.USD","LU2347655156.SGD","LU1878469433.USD","TG","BK4504","LU0912757837.SGD","LU1668664300.SGD","PML","LU2028103732.USD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640926692","title":"Agilent receives FDA approval for expanded use of PD-L1 IHC 22C3 pharmDx","url":"https://stock-news.laohu8.com/highlight/detail?id=2640926692","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640926692?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:50","pubTimestamp":1780433431,"startTime":"0","endTime":"0","summary":"The company states: “Agilent (A) Technologies announced that the FDA has approved the expanded use of PD-L1 IHC 22C3 pharmDx, Code GE006, for use o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agilent-receives-fda-approval-for-expanded-use-of-pd-l1-ihc-22c3-pharmdx-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agilent-receives-fda-approval-for-expanded-use-of-pd-l1-ihc-22c3-pharmdx-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4162","LABU","LU1721428933.USD","LU2041044095.USD","BK4567","LU2413666426.HKD","LU2413666699.HKD","PD","LU1169589451.USD","BK4585","LU0347712357.USD","LU2229751404.USD","LU2092937221.SGD","LU1169590202.USD","LU1165135440.EUR","BK4588","IE00BN0W2W23.USD","BK4121","IHC","IE00BN0W2T93.GBP","LU2089279066.USD","IE00BN0W2V16.EUR","LU1543694498.USD","A","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959294","title":"PagerDuty management presents at BofA Securities Global Technology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959294","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959294?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:02","pubTimestamp":1780315333,"startTime":"0","endTime":"0","summary":"PagerDuty will present at the Bank of America Securities 2026 Global Technology Conference on June 2 at 2 p.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PagerDuty Inc. published the original content used to generate this news brief via Business Wire  on June 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL6Pmk5q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU0320765646.SGD","LU1880398471.USD","LU0130103400.USD","LU0170899867.USD","LU0234570918.USD","LU0787776722.HKD","LU0128525689.USD","IE0034235188.USD","IE00BKVL7J92.USD","LU0306807586.USD","LU0868494617.USD","LU0149725797.USD","BK4553","IE0002270589.USD","LU0310800965.SGD","LU1496350502.SGD","LU0130517989.USD","LU1506573853.SGD","PD","LU1496350171.SGD","IE00BLSP4239.USD","LU1804176565.USD","LU1280957306.USD","LU0070302665.USD","IE00BBT3K403.USD","IE0001KFT4U8.USD","LU0208291251.USD","BK4585","LU1267930227.SGD","LU2129689514.USD","LU2265009873.SGD","IE00BFXG1179.USD","LU0203345920.USD","LU0321505868.SGD","BK4534","LU0203347892.USD","BAC","BK4588","IE00B19Z3B42.SGD","LU1894683348.USD","IE00BLSP4452.SGD","LU1791807156.HKD","BK4207","LU0106831901.USD","LU0477156953.USD","LU1880398554.USD","LU1883839398.USD","BK4023","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951863","title":"Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951863","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951863?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315200,"startTime":"0","endTime":"0","summary":"One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic anti-tumor activity in metastatic PD-1 relapsed cutaneous melanoma and metas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304266/0/en/Immatics-Presents-Clinical-Activity-and-Response-Dynamics-of-Anzu-cel-PRAME-Cell-Therapy-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","IE0031619046.USD","IMTX","LU2065731478.USD","BK4187","IE00B7SZL793.SGD","PD","BK4139","CRS","BK4023","IE00B19Z4B17.USD","LU0963586101.USD","IE00B66KJ199.SGD","LU1169590202.USD","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":199,"code":"91000000","status":"200"}]}}